Lalith Pharma-Marketing Profile
Key Indicators
- Authorised Capital ₹ 0.81 M
as on 12-12-2024
- Paid Up Capital ₹ 0.80 M
as on 12-12-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.01 M
as on 12-12-2024
- Revenue 32.91%
(FY 2022)
- Profit 7.41%
(FY 2022)
- Ebitda 27.62%
(FY 2022)
- Net Worth 0.11%
(FY 2022)
- Total Assets 29.77%
(FY 2022)
About Lalith Pharma-Marketing
The Corporate was formerly known as Lalit Pharma-Distributors Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.81 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹1.01 M.
Rajeshkumar and Sangeetha serve as directors at the Company.
- CIN/LLPIN
U24232KA2008PTC045345
- Company No.
045345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2008
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Lalith Pharma-Marketing Private Limited offer?
Lalith Pharma-Marketing Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Pain Relief Drugs & Pharmaceuticals, Pain Killers, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Lalith Pharma-Marketing?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar  | Director | 21-Feb-2008 | Current |
| Sangeetha | Director | 17-Mar-2010 | Current |
Financial Performance of Lalith Pharma-Marketing.
Lalith Pharma-Marketing Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.91% increase. The company also saw a slight improvement in profitability, with a 7.41% increase in profit. The company's net worth moved up by a moderate rise of 0.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lalith Pharma-Marketing?
In 2019, Lalith Pharma-Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Apr 2009 | ₹1.01 M | Open |
How Many Employees Work at Lalith Pharma-Marketing?
Unlock and access historical data on people associated with Lalith Pharma-Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lalith Pharma-Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lalith Pharma-Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
